2026

• Translating tumor epigenetic subtyping into methylome network-based prognostic models in early-stage NSCLC: results from the prospective MOBIT study

  Chwiałkowska Karolina, Niemira Magdalena, Zeller Anna [i in.], Journal of Translational Medicine, 2026, s.52 pp. Przejdź do dokumentu po identyfikatorze cyfrowym DOI:10.1186/s12967-026-07957-x

   
• A real-world, single-center, observational retrospective experience of durvalumab treatment after concomitant chemoradiation for unresectable stage III non-small cell lung cancer

  Wojskowicz Agnieszka, Skalij Piotr, Hempel Dominika [i in.], Cancers, 2026, vol. 18, nr 6, s.19 pp. Przejdź do dokumentu po identyfikatorze cyfrowym DOI:10.3390/cancers18061044